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Advances in chemistry and physics have profound effects on neuroimaging. Current and future progress
in these disciplines will continue to aid in efforts to visualize neural circuitry, particularly in deeper layers
of the brain.In ‘‘Histology of the Nervous System of
Man and Vertebrate,’’ Santiago Ramo´n
yCajal stated that ‘‘the key to understand-
ing turns on the nature of available instru-
mentation’’ and that ‘‘current methods
and ideas are entirely dependent on
continuing progress in chemistry and
physics, which remain the principle allies
of the naturalist’’ (Ramon y Cajal, 1995).
He would know; although optical micro-
scopy was first used to observe biological
samples more than 200 years before his
time, only with the emergence of high-
quality commercial microscopes and
Cajal’s own improvement upon Camillo
Golgi’s silver chromate method, did he
make the series of discoveries that led to
the neuron doctrine and the beginning of
modern neuroscience.
Chemistry and physics have gone
through paradigm-shifting changes of
their own in themore than 100 years since
Cajal’s declaration, but their roles in
neuroscience have remained the same:
they provide the foundation for and set
the limits on the methods with which
questions in neuroscience are answered
and understanding is reached. A perfect
example is two-photon fluorescence
microscopy (TPFM), a powerful technique
for imaging structures in living tissues.
Since its invention 25 years ago (Denk
et al., 1990), TPFM has become an essen-
tial tool for structural and functional imag-
ing of neurons at subcellular spatial reso-
lution in scattering brains. Here we
examine it in relationship to physics and
chemistry, for they help us understand
the limitations and the future directions
of not only TPFM, but also other imaging
modalities.
Fluorescence generation occurs when
a molecule returns from an excited elec-1242 Neuron 83, September 17, 2014 ª2014tronic state to its ground electronic state
by emitting a photon. The molecule may
reach the excited state by absorbing a
photon at a particular wavelength, or by
absorbing two photons of a much longer
wavelength simultaneously. The probabil-
ity of two-photon absorption, however, is
exceedingly small and thus requires high-
intensity excitation light. Mode-locked
near-infrared (0.7–1.1 mm, NIR) lasers
with short pulse widths have the peak po-
wer necessary for two-photon fluores-
cence generation for most visibly fluores-
cent dyes. Experimentally, the energy
carried by these short pulses is concen-
trated by a high-numerical-aperture (NA)
microscope objective to a small focal vol-
ume, within which the light intensity is high
enough for effective two-photon fluores-
cence generation. This confinement of
fluorescence emission to a focus reduces
photo-induced bleaching and damage
that would otherwise occur with confocal
or widefield microscopy (Denk and Svo-
boda, 1997). Typically, the laser focus is
scanned across the sample point by
point, and the fluorescence collected
and measured at each point is used to
build up the image. The resolution of a
TPFM is determined by the size of the
focus. At moderately high NA (e.g., 0.8),
a TPFM can resolve subcellular features
such as dendritic spines.
Themost technically challenging part of
building a TPFM is the light source. After
the emergence of commercial ultrafast
lasers in the 1990s, both homebuilt and
commercial two-photon fluorescent mi-
croscopes started to populate labora-
tories worldwide. One of themain reasons
for the popularity of TPFM, particularly in
neuroscience, is that it allows 3D imaging
in scattering tissues such as live mamma-Elsevier Inc.lian brains (Svoboda and Yasuda, 2006).
Because the fluorescence is only gener-
ated at the focus, all the fluorescent pho-
tons, scattered or not by the tissue,
constitute a useful signal that reflects
the sample fluorescent properties at
the focal position. In contrast, widefield
microscopy techniques (e.g., light-sheet
microscopy [Ahrens et al., 2013]) require
minimal scattering of the fluorescent
signal to form a sharp image, and thus
are limited to transparent samples.
What ultimately made TPFM as power-
ful as it is now is the progress in chemistry,
specifically, the developments of versatile
fluorescent reagents that can selectively
stain the structures of interest and even
report the occurrence of physiological
events. In the brain, genetic and syn-
thetic fluorescent reporters are now
routinely employed in laboratories to
monitor morphological and functional
changes (Helmchen et al., 2011). For
example, recently developed genetically
encoded calcium sensors (Chen et al.,
2013) have single action potential sensi-
tivity and, when combined with TPFM,
allow neuronal activities to be monitored
at synaptic, cellular, and network level in
the brains of awake, behaving animals
(Grienberger and Konnerth, 2012).
To completely map the morphology
and function of the brain in a live animal,
one needs to be able to image neurons
throughout the brain, preferably at the
same subcellular resolution that provides
synaptic-level information. However,
most in vivo studies using TPFM in the
scattering mammalian brains are limited
to the first few hundred microns, which
prevents us from understanding the
anatomical and functional inner workings
of even the most superficially located
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tors that limit imaging depth and optical
manipulation (e.g., optogenetics) are opti-
cal aberration and attenuation.
Aberration is familiar to anyone who has
gazed out of a rain-drenched window.
Optically, light rays on their way to a
focus get distorted by structures with
different indices of refraction. Instead of
converging to the same spot and inter-
fering constructively there, they form an
enlarged focus with reduced intensity.
The same thing happens when the excita-
tion laser of TPFM is focused through a
cranial window and into the brain using a
water-dipping objective: both the window
and the brain itself aberrate the laser
beam and lead to an enlarged, weaker
focus, reducing both the resolution and
the signal of TPFM. The sample-induced
aberration increases with increased
imaging depth, leading to the common
observation that the image becomes
less ‘‘sharp.’’ Such aberration is not
limited to mammalian brains or TPFM:
even relatively transparent samples such
as zebrafish andC. elegans aberrate light,
often significantly, in widefield methods.
Aberrations experienced by fluorescence
photons when they traverse the sample
before reaching the detection camera
lead to the loss of signal and image
fidelity.
Aberration, at least conceptually, is an
easy problem to solve. If we can modify
the wavefront of the light rays with a
deformable mirror to exactly balance
and cancel out the sample-induced aber-
rations as the light travels to the focus,
diffraction-limited, ideal imaging quality
can be recovered. These adaptive optics
(AO) techniques were first proposed for
ground-based telescopes to observe ce-
lestial objects through Earth’s turbulent
atmosphere. In direct analogy to micro-
scopy, this turbulence distorts the light
emitted by the celestial object of interest
and leads to a blurry image with tempo-
rally varying intensity and position (e.g.,
‘‘twinkle, twinkle, little star’’). This distor-
tion can be directly measured with a
wavefront sensor and the information
used to control the surface of a deform-
able mirror to cancel it out. Sometimes,
when the light from the star itself is too
faint, an artificial guide star may be gener-
ated by using a laser to excite the sodium
atoms in the upper atmosphere. Spectac-ularly successful in astronomy, the astro-
nomical AO technique can be directly
adapted to correct the aberration of trans-
parent tissue. In one example (Wang
et al., 2014b), the artificial guide star was
generated by two-photon excitation of
fluorescent proteins in zebrafish brain,
and neuronal processes, unresolved
without AO, became distinct after correc-
tion. At depth in mammalian brains, how-
ever, the light from an induced fluorescent
guide star is too highly scattered to be
used to measure the wavefront distortion
directly (but see below). To address this
problem, we have developed several
methods (Ji et al., 2010; Wang et al.,
2014a), where, by manipulating intensity
or phase of light falling on different parts
of the microscope objective back aper-
ture, we can measure the aberration
associated with strongly scattering sam-
ples such as the mouse brain. Unlike
atmospheric turbulence that changes on
millisecond scale, the brain-induced ab-
erration is generally stable over hours,
and the same correction can improve im-
age quality over hundreds of microns (Ji
et al., 2012). It is thus well suited for in vivo
brain imaging, where large field of view
and extended imaging duration are often
needed. With AO, we can routinely
resolve basal dendritic spines of L5 pyra-
midal neurons and functionally image
axonal boutons in L4 in mouse cerebral
cortex in vivo.
A more difficult problem that limits im-
aging depth is light attenuation caused
by absorption and scattering, both of
which reduce intensity exponentially with
depth. In the brain, hemoglobin absorbs
blue and green light strongly, but not red
or NIR light (this is why blood appears
red to our eye). At the other end, for wave-
lengths beyond 1 mm, water becomes the
dominant absorber. Within this ‘‘optical
window’’ (650–1,200 nm), where the light
used for two-photon excitation falls, the
major source of its attenuation in brain
tissue is not absorption, but scattering.
Scattering is also a familiar phenome-
non in our daily life: anything that is not
visually transparent scatters visible light
(e.g., fog, clouds, milk, skin, mouse brain).
In the mammalian brain, cytosol inter-
mixes with many lipid-rich structures
(e.g., myelin sheath, mitochondria, and
endoplasmic reticulum), which with sizes
close to the wavelengths of visible andNeuron 83, SepNIR light, dominate the scattering pro-
cess. Therefore, for TPFM, both the
excitation (usually in NIR) and emission
(usually in visible) light are attenuated by
scattering. Fluorescence emitted in the
blue-to-yellow band is additionally ab-
sorbed by hemoglobin and somemetabo-
lites. To reach a high focal intensity for
two-photon excitation, one has to in-
crease the laser power exponentially
with depth. Eventually, the intensity at
the surface of the tissue is sufficient to
excite superficial fluorescent structures
without needing the confinement at the
laser focus. When this out-of-focus back-
ground overwhelms the in-focus signal,
further increase of the excitation intensity
does not improve image quality, and the
imaging depth limit of a standard TPFM
is reached (Theer et al., 2003) (in live
samples, photo-induced damages may
happen well before this limit is reached).
Correcting sample-induced aberration
could extend the imaging depth limit by
improving the in-focus signal, but scat-
tering still poses the ultimate limit.
Reagents have been developed to
improve the transparency of fixed brain
tissue by increasing tissue optical homo-
geneity. The varying refractive index of
native brain can be matched by either
raising the refractive index of the aqueous
fraction of the tissue (Hama et al., 2011) or
replacing the lipids with a hydrogel-based
infrastructure (Chung et al., 2013). A
physiological reagent that can clear living
mammalian brains, however, has yet to be
found. For now, scattering is here to stay.
For some structures (e.g., hippocam-
pus in mouse), the overlaying tissue may
be removed to provide optical access
without notably impacting the question
under investigation. However, such an
approach is not realistic for more deeply
buried nuclei (e.g., amygdala, hypothala-
mus). In such cases, endoscopy is more
practical. With a long history of its own
(first developed in 1806), endoscopes
are miniature imaging devices that may
be directly inserted into the organ and
are widely used in the medical field
for diagnosis and treatment. Microendo-
scopes based on gradient refractive index
(GRIN) lenses or optical fibers have been
developed to image the mammalian brain
with cellular resolution. The single-photon
excitation versions of these instruments
are small enough to be mounted on atember 17, 2014 ª2014 Elsevier Inc. 1243
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2011). Its widefield detection modality
makes it insensitive to brain motion, but
with the concomitant disadvantage
of having no optical sectioning capa-
bility. Two-photon microendoscopy al-
lows high-resolution volume imaging of
neurons, but is sensitive to brain motion,
since it is slower and produces images
serially in time. It is thus better suited to
head-fixed animals. Commercially avail-
able GRIN lenses as small as 0.5 mm in
diameter can provide an imaging field of
view of 0.2 3 0.2 mm2 at single-neuron
resolution. While future improvements of
these devices can be expected, we have
also improved their performance by cor-
recting the aberrations induced by the
GRIN lens itself with AO.
Evenwithout clearing reagents or tissue
removal, scattering is not insurmountable.
Just as wavefront shaping can cancel out
the optical aberration, the wavefront of
the excitation can be manipulated on a
much finer scale to partially compensate
for scattering. Sharp images have been
generated with large signal gain from light
that has traveled many scattering lengths
through tissue (e.g., Tang et al., 2012; Ya-
qoob et al., 2008). However, because the
scattering profile of biological samples
varies rapidly in space and often also in
time, to correct scattering in a brain vol-
ume hundreds of microns in dimension,
many thousands or millions of corrective
wavefronts would need to be measured
and applied at speeds far beyond the ca-
pabilities of current methods and instru-
mentation. Therefore, except for niche
applications where micron-sized fields of
view are sufficient, the microendoscopy
approach remains the most accessible
and robust imaging method for deeply
buried nuclei in the mammalian brain.
Despite the significant role that physics
has played in improving neuroimaging as
described above, the advances arising
from chemistry have remained the most
accessible, because reagents are gener-
ally inexpensive and simple to dissemi-
nate. As mentioned above, both tissue
scattering and sample-induced aberra-
tion are weaker at longer wavelengths,
and absorption is smallest in the far-red
to NIR window. Hence, deeper imaging
may be reached simply by employing
red-shifted fluorescent dyes (Kobat
et al., 2009). Indeed, with even longer1244 Neuron 83, September 17, 2014 ª2014wavelengths for three-photon excitation,
subcortical structures in mouse brain
have been imaged in vivo (Horton et al.,
2013). A red genetically encoded cal-
cium indicator, when combined with the
continuing improvements in optics (e.g.,
AO, better excitation light sources in
NIR, and objectives designed tomaximize
the collection of scattered photons), may
make functionally imaging the whole
mouse cortex a reality in the near future.
The longer wavelengths of both the
excitation and fluorescence photons of
deep red or IR reagents make them
less scattered and absorbed than their
shorter-wavelength counterparts. Hence,
widefield detection methods that so far
have been limited to visibly transparent
samples by scattering, such as structured
illumination or light-sheet microscopy,
may become viable alternatives to TPFM
in certain applications in the scattering
brains. With their fast parallel readout,
these methods are more compatible with
reagents that rely on rapid contrast mech-
anisms (e.g., voltage-sensitive dyes). For
AO, my lab has also used fluorescence
of the red-shifted dyes as a guide star
for direct wavefront measurement and
correction of aberration in the mouse
brain at 700 mm depth, something not
possible with traditional green/yellow-
emitting dyes.
No matter how clever the physical prin-
ciple, the power of every imaging method
is confined by the practically achievable
signal-to-noise ratio, which is often
limited by the brightness of the dye—the
usefulness of many fast imaging tech-
niques is currently limited by the need to
average the data in time to achieve suffi-
cient signal. Regardless of the color of
the fluorescence, a real game changer
for all imaging endeavors would be a fluo-
rescent reagent 104 3 (or even 100 3 )
brighter than the existing ones. Before
such a magic dye is found, however,
with the currently available fluorescent
probes and standard microscopes, there
are things we can do to make life easier.
First, be mindful about aberration. Use
sample preparation protocols that intro-
duce minimal aberration (i.e., anything
with a refractive index different from that
of the immersion media of the objective).
Minimize brain-induced aberration by
positioning the brain as perpendicular to
the optical axis of the microscope objec-Elsevier Inc.tive as possible (otherwise, the correction
collar of the microscope objective is of
little help). Be smart about labeling strat-
egy. When imaging neurons at depth,
only label the neurons of interest—
reducing fluorescence elsewhere delays
the appearance of the out-of-focus back-
ground when increasing the excitation
power. Finally, a word of caution: the act
of observation itself may alter the state
of the system. Although often billed as
noninvasive, optical imaging is no excep-
tion when it comes to the potential for
unintended consequences, caused by
introducing tens to hundreds of milliwatts
of light and millions to billions of fluores-
cent molecules into each neuron. Each
system has a practical photon budget,
i.e., the maximal amount of photons
extractable before photon- or probe-
induced artifacts make the system non-
physiological. Spend it wisely.
It seems fitting to end this essay with
Cajal, who predicted back before the
quantum revolution that ‘‘in the distant
future, when science has developed vast
resources and chemistry and physics
are no longer regarded as separate ways
of approaching the same mechanisms at
the level of atoms, anatomy will be an
even more rigorous discipline,’’ where
questions on function, mechanism, and
development of the brain may finally
be answered. That distant future has
become a reality, and it is now up to us
to use the, albeit still imperfect, tools
developed in physics and chemistry
wisely to answer the fundamental ques-
tions of how the brain works.
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